May 31, 2021 / 12:30PM GMT
Operator
Ladies and gentlemen, good day, and welcome to Aurobindo Pharma Limited Q4 FY '21 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Krishna Kiran. Thank you, and over to you, sir.
Krishna Kiran - Aurobindo Pharma Limited - IR Officer
Thank you. Good evening, and a warm welcome to our fourth quarter full year FY '21 Earnings Call. I am Krishna Kiran from Aurobindo Pharma Investor Relations team. We hope you have received the Q1 FY '21 financials and the press release that were sent out earlier. These are also available on our website.
With me, we have our senior management team represented by Mr. P.V. Ramprasad, Chairman, Aurobindo Pharma USA; Mr. N. Govindarajan, Managing Director; Mr. Sanjeev Dani, COO, Head of Formulations; Mr. Santhanam Subramanian, CFO; Mr. Swami Iyer, CFO, Aurobindo Pharma USA; and Mr. Arvind Bothra, Head, Investor Relations and Corporate Communication.
We will begin the call with summary highlights from the management
Full Year 2021 Aurobindo Pharma Ltd Earnings Call Transcript
May 31, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers